Eosinophil apoptosis--pathophysiologic and therapeutic implications.
Simon
H U
HU
Department of Pharmacology, University of Bern, Switzerland.
D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis; D016207:Cytokines / Q000494:pharmacology / Q000627:therapeutic use; D004802:Eosinophilia / Q000503:physiopathology*; D004804:Eosinophils / Q000187:drug effects / Q000473:pathology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000276:immunology*; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D015848:Interleukin-5 / Q000037:antagonists & inhibitors / Q000378:metabolism; D020024:Leukotriene Antagonists; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D006634:Histamine H1 Antagonists; D015848:Interleukin-5; D020024:Leukotriene Antagonists; D010726:Phosphodiesterase Inhibitors